ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1348	National Cancer Institute	Html	en	Childhood Brain and Spinal Cord Tumors Treatment Overview (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of various childhood brain tumors.	extent 0.337038 subsequent treatment 0.517666 Secondary tumors 0.579906 clinical parameters 0.491035 tumor recurrence. 0.623825 survival rates 0.51115 Long-term management 0.517392 chemotherapy 0.381898 cancer therapy 0.545899 complete evaluation 0.500262 malignant tumors 0.805007 malignant lesions. 0.574087 surgical re-resection 0.493219 need 0.367173 adolescents 0.338935 treatment-related brain necrosis 0.687273 diagnosis 0.335644 long-term survivors. 0.521208 secondary tumor 0.621568 delay 0.350588 radiation therapy 0.839862 reappearance 0.354633 Long-term sequelae 0.545468 late effects 0.655763	initial presence 0.550902 childhood cancer mortality 0.80921 CNS 0.340422 surgical intervention 0.48867 Systemic relapse 0.562929 Refer 0.342732 multidisciplinary approach 0.498495 specific information 0.517079 lower-grade lesions 0.50599 preliminary results 0.50527 molecular makeup. 0.495814 initial tumor type 0.822989 initial treatment 0.69405 primary tumor site 0.789307 close monitoring 0.52126 tumor transformation 0.62382 younger children 0.509243 adolescent cancer survivors 0.999281 childhood brain tumors 0.792254 Dramatic improvements 0.534814 PDQ summary 0.529827 Biopsy 0.34098 neurologic development 0.517779 time 0.38324	CLICK HERE
1468	National Cancer Institute	Html	null	Testicular Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of testicular cancer.			CLICK HERE
1484	National Cancer Institute	Html	en	Pituitary Tumors Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of pituitary tumors.	treatment 0.39139 diagnostic imaging choice 0.347546 magnetic resonance imaging 0.340677 pituitary tumors 0.690926 pituitary adenomas 0.92392 medical therapy exists. 0.351515 pituitary lesion 0.527537 transsphenoidal microsurgical approach 0.343275 visual field 0.394767 cell-type specific presentations 0.354594 medical therapy 0.38784 pituitary gland 0.541344 gonadotroph adenomas 0.356536 important clinical presentation 0.355104 pituitary carcinomas 0.731658 useful diagnostic tool 0.338617 inactive pituitary adenomas 0.650057 endocrine-inactive adenomas 0.359468 pituitary adenoma 0.802139 pituitary apoplexy 0.612406 hormone-producing adenomas 0.35841 Conventional radiation therapy 0.361094 functional criteria 0.339781 GH-receptor antagonists 0.338498	adjunctive radiation therapy 0.355238 MRI scan 0.341418 effective medical treatment 0.350208 pituitary disorders 0.546502 appropriately selected patients 0.348512 dopamine analogues 0.357798 pituitary tumor 0.625147 Sagittal T1-weighted images 0.340975 patients 0.403665 surgically high-risk patients 0.358813 adjunctive medical therapy 0.353866 Hormone-secreting pituitary carcinomas 0.652967 significant suprasellar extension 0.453203 safe surgical treatment 0.370545 gross total tumor 0.361957 surgical management 0.338442 pituitary adenoma literature 0.647061 pituitary neoplasms 0.533177 postoperative radiation therapy 0.355824 radiation therapy 0.637553 somatostatin analogues 0.402133 ergot-derived dopamine agonists 0.339339 pituitary tumors. 0.521498	CLICK HERE
1623	National Cancer Institute	Html	null	Gonzalez Regimen (PDQ®)–Health Professional Version	The Gonzalez regimen is a specialized diet that uses enzymes, supplements, and other factors in cancer management based on a theory that involves the use of pancreatic enzymes to help the body get rid of toxins that lead to cancer. Read about existing clinical data in this expert-reviewed summary.			CLICK HERE
1721	National Cancer Institute	Html	en	Cruciferous Vegetables and Cancer Prevention	A fact sheet that summarizes the results of studies about cruciferous vegetables and cancer. Includes a list of cruciferous vegetables and dietary recommendations.	Netherlands—the Netherlands Cohort 0.505069 vegetable consumption 0.464589 cruciferous vegetables 0.977553 additional cohort study 0.516082 lung cancer 0.572949 anticancer effects 0.474858 colorectal cancer risk 0.625293 U.S. analysis—using data 0.461382 Breast Cancer Detection 0.503706 case-control studies 0.513186 prostate cancer risk 0.623248 lower risk 0.488713 glutathione S-transferase M1 0.504449 American Journal 0.4921 cruciferous vegetable intakes 0.595836 dark-green vegetables 0.522884 cancer chemopreventive actions 0.501377 cruciferous vegetable intake 0.689816 Cancer Epidemiology 0.57031 cohort studies 0.539353 glutathione S-transferase polymorphisms 0.4667 European Prospective Investigation 0.461912 cohort study 0.686602 cancer prevention 0.479265 United States 0.545427	Different vegetables 0.524746 multiethnic case-control study 0.487149 National Cancer Institute 0.594926 Project follow-up cohort 0.488384 Multiethnic Cohort Study 0.506189 good fiber source 0.467963 cancer researchers 0.489622 prospective cohort study 0.510047 breast cancer risk 0.615894 fruit consumption 0.483024 Clinical Nutrition 0.460261 breast cancer 0.641649 colon cancer risk 0.523965 biologically active compounds 0.464394 Goldbohm RA 0.48606 lung cancer risk 0.545247 C. Brassica vegetables 0.534883 prospective study 0.585742 glutathione S-transferase 0.517935 lung cancer mortality 0.501562 et al 0.817121 cancer risk 0.800364 Netherlands Cohort Study 0.590813 lower lung cancer 0.502455	CLICK HERE
1771	National Cancer Institute	Html	es	Sofocos y sudores nocturnos (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de las causas y el tratamiento de los sofocos y sudores nocturnos en los pacientes de cáncer.	cancer treatment 0.37896 Treatment Group Trial 0.316121 ncctg trial 0.313822 Treatment Group hot 0.319139 menopausal hot 0.328045 Loprinzi CL 0.615617 trial with 0.311 menopausal symptoms 0.33934 Sin embargo 0.333136 Barton DL 0.356229 with early stage 0.313223 black cohosh 0.329892 Sloan JA 0.313934 ameliorating tamoxifen-induced hot 0.310913 randomized trial 0.317475 with hot 0.314342 phase iii 0.323066 active nonhormonal hot 0.311258 symptoms after breast 0.31045 Natl Cancer Inst 0.330125 during menopausal hot 0.313013 North Central Cancer 0.333247 tamoxifen-induced hot 0.32746 Women's Health Initiative 0.336331 Cancer Ther 0.316362	breast carcinoma 0.310376 Support Oncol 0.317335 randomized controlled 0.353057 Initiative Randomized Trial 0.310959 Cognitive behavioural treatment 0.310884 hot flash studies 0.31899 Hot Flash Related 0.322478 experiencing tamoxifen-induced hot 0.310785 problematic menopausal hot 0.31265 hierba sonajero 0.329084 estrogen replacement therapy 0.321006 Support Care Cancer 0.31053 Cancer Res Treat 0.338604 Cancer Treatment Group 0.35326 after breast 0.314947 Clin Oncol 0.532082 breast cancer 0.920092 health initiative randomized 0.310524 hot flash 0.362781 Pilot evaluation 0.324608 early stage breast 0.318416 Central Cancer Treatment 0.352938 learned from hot 0.311156 Stearns V 0.318536	CLICK HERE
1777	National Cancer Institute	Html	es	El dolor y el cáncer (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del dolor como una complicación a causa del cáncer o su tratamiento. Se tratan abordajes para el control y el tratamiento del dolor relacionado con el cáncer.	Moderate Cancer Pain 0.337641 among patients with 0.313833 Curr Pain Headache 0.353041 Palliat Nurs 0.30942 Chronic Pain Syndromes 0.356907 Breakthrough Pain Study 0.329475 Pain Questionnaire 0.327384 Jensen MP 0.310829 Cancer Therapy 0.30947 with breast cancer 0.313155 Edmonton Symptom Assessment 0.309493 Pain Terms 0.351866 pain management 0.434176 Natl Cancer Inst 0.310759 Hui D 0.310443 pain syndromes 0.398674 Faces Pain Scale 0.329845 Pain Res 0.344114 patients with 0.479951 Pain Symptom Manage 0.524062 Pain Experience among 0.326556 Pain Management Nursing 0.328639 chronic pain 0.526592 dolor).¿El dolor 0.346176 Oncol Nurs Forum 0.309327	peor dolor 0.357775 pain assessment 0.342098 Care Cancer 0.331083 breakthrough pain 0.366572 palliative care 0.309739 Hosp Palliat Care 0.329839 Faces Pain 0.365306 Pain related 0.328906 pain assessment toolkit 0.327388 pain control 0.351552 patients with depression 0.30909 Brief Pain Inventory 0.377512 Pain Headache Rep 0.352431 cancer pain 0.974628 cancer pain prognostic 0.363979 pain experience 0.342944 Clin Oncol 0.363176 Palliat Med 0.324432 pain's interference with 0.332203 breast cancer 0.321556 Bruera E 0.316817 edmonton staging system 0.310908 systematic review 0.31986 Faces Pain Scale-Revised 0.327413	CLICK HERE
1931	National Cancer Institute	Html	es	Tratamiento de los tumores de ovario de bajo potencial maligno (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de los tumores de ovario de bajo potencial maligno.	potencial maligno recidivantes 0.922565 siguientes procedimientos 0.427427 tarde.ampliar ecografía abdominal 0.259992 estadio iv 0.702134 estadio tardío quizás 0.295045 siguientes aspectos 0.213133 rayos x 0.188575 estadio ic 0.522053 estadio ib 0.526427 estadio ia 0.52265 National Cancer Institute 0.172435 siguientes riesgos 0.159887 tratamiento quizás 0.234452 Instituto Nacional 0.353292 áreas anormales.ampliar examen 0.232843	estadio iiia 0.49525 PDQ Tratamiento 0.250127 estadio iiic 0.497145 estadio iiib 0.498374 estadio iia 0.510853 estadio iib 0.521745 estadio iic 0.517926 Physician Data Query 0.359777 potencial maligno causa 0.737758 maligno causa efectos 0.613505 siguientes enlaces 0.168488 ecografía transvaginal.Ampliar 0.196606 histerectomía abdominal 0.202556 siguientes pruebas 0.233116	CLICK HERE
1955	National Cancer Institute	Html	es	Tratamiento de la micosis fungoide (incluso el síndrome de Sézary) (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de la micosis fungoide (incluso el síndrome de Sézary).	siguientes procedimientos 0.303227 células madre 0.320527 estadio iv 0.313697 La micosis fungoide 0.416261 llamada terapia 0.301315 Estadio IIA 0.301756 vía oral 0.300639 Estadio IIB 0.301746 rayos x 0.300779 estadio ivb 0.303346 estadio ib 0.303433 enlace drugs approved 0.306299 estadio ia 0.303396 radioterapia ultravioleta 0.303448 micosis fungoide 0.995318 célula madre mieloide 0.305243 células t 0.307128 madre sanguíneas maduras 0.302125 luz solar 0.300631 estadio iva 0.303278	quimioterapia sistémica 0.305438 National Cancer Institute 0.300622 Instituto Nacional 0.301086 célula madre linfoide 0.305924 PDQ Tratamiento 0.301318 partículas minúsculas 0.300672 presente sección 0.300525 llamada fotoquimioterapia 0.300664 Physician Data Query 0.302237 Non-Hodgkin Lymphoma 0.303589 estadio iii 0.306895 lesiones cutáneas 0.300795 radiación ultravioleta a 0.301198 célula madre 0.319745 luz ultravioleta 0.30088 ósea elabora células 0.304191 radiación ultravioleta 0.315951 Sézary recidivantes 0.302362 siguientes sumarios 0.301672 siguientes pruebas 0.301109	CLICK HERE
3578	National Cancer Institute	Html	en	Research Areas	Making sustained progress against cancer requires advances across the research continuum. Learn about the breadth of NCI's work and the programs the institute supports to advance cancer research.	National Cancer Institute 0.966549		CLICK HERE